{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13705",
      "entity_text" : "ActRIIB",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05664",
      "entity_text" : "FS-315",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Many preclinical and clinical studies demonstrate that a therapeutic modality based on inhibition of TGF-beta superfamily proteins / ActRIIB signaling by follistatin (FS-315) is a promising strategy for treating muscle wasting XREF_BIBR, XREF_BIBR.",
  "reading_complete" : "2020-08-02T14:33:40Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:32:01Z",
  "trigger" : "signaling",
  "evidence" : [ "ActRIIB signaling by follistatin (FS-315" ],
  "pmc_id" : "6276093",
  "score" : 0
}